| Patents for A61P 33 - Antiparasitic agents (21,787) |
|---|
| 04/21/2004 | EP1410018A1 Method for detecting modultators of notch signalling |
| 04/21/2004 | EP1409715A2 Methods and materials relating to neurotrimin-like polypeptides and polynucleotides |
| 04/21/2004 | EP1409677A2 Receptors and membrane-associated proteins |
| 04/21/2004 | EP1409665A2 Method to generate non virulent microorganisms from pathogenic ones trough permanent genetic modification of their biological membrane for vaccine production |
| 04/21/2004 | EP1409655A2 Immunoglobulin superfamily proteins |
| 04/21/2004 | EP1409535A2 Human secreted proteins |
| 04/21/2004 | EP1409533A2 Recombinant plasmodium falciparum merozoite protein-1/42 vaccine |
| 04/21/2004 | EP1409005A1 Modulators of notch signalling for use in immunotherapy |
| 04/21/2004 | EP1408987A2 Tetracycline compounds having target therapeutic activities |
| 04/21/2004 | EP1196159B1 Use of tosylchloramide(s) for treating diseases of the skin, mucous membranes, organs and tissues |
| 04/21/2004 | CN1490409A Preparing method for recombinant chBJSTWO protein and use thereof |
| 04/21/2004 | CN1490009A Sustained release injection containing medicine against coccindian |
| 04/21/2004 | CN1490004A Freeze-dried tinidazole preparation and preparing method thereof |
| 04/20/2004 | US6723736 For therapy inflammation, inflammatory diseases, immunologic diseases and other diseases mediated by tumor necrosis factor-alpha (tnf-alpha) and/or interleukin 6 or 10 and/or enzyme cyclooxygenase-2 (cox-2) |
| 04/20/2004 | US6723328 A homogenized, killed pure microsporum canis culture provided in a carrier wherein the culture is isolated by filtration. |
| 04/16/2004 | CA2408207A1 Peptides binding protein phosphatase 2a and polynucleotides coding them |
| 04/15/2004 | WO2004030685A2 Use of il-2 receptor antibodies to prevent toxicity associated with amphotericin b antimycotic therapy |
| 04/15/2004 | WO2004012757A3 Apolipoprotein l-i for the treatment or diagnosis of prypanosomaldiseases |
| 04/15/2004 | WO2003066807A3 Method of inhibiting pathogenicity of infectious agents |
| 04/15/2004 | WO2003059352B1 Use of a novel class of drugs for the treatment of parasitic diseases |
| 04/15/2004 | WO2003049723A8 Use of protease-activated receptor-2 inhibitor in the manifacture of a medicament for treating delayed hypersensitivity |
| 04/15/2004 | WO2003004604A9 Phage displayed pdz domain ligands |
| 04/15/2004 | US20040072909 Veterinary compositions for the treatment of parasitic diseases |
| 04/15/2004 | US20040072168 Novel deoxynucleoside kinase enzyme variants |
| 04/15/2004 | US20040071663 Pesticidal and antiparasitic compositions |
| 04/15/2004 | CA2500723A1 Use of il-2 receptor antibodies to prevent toxicity associated with amphotericin b antimycotic therapy |
| 04/14/2004 | EP1406998A2 Liver engrafting cells, assays, and uses thereof |
| 04/14/2004 | EP1406639A2 Method for enhancing the effectiveness of cancer therapies |
| 04/14/2004 | EP1406615A1 Kinase inhibitors and the use thereof |
| 04/14/2004 | EP1406602A2 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors |
| 04/14/2004 | EP1406598A1 Lymphatic drug delivery system |
| 04/14/2004 | EP0935465B1 Novel substituted imidazole compounds |
| 04/14/2004 | CN1145636C C-4'-substituted macrolide derivatives |
| 04/08/2004 | WO2004028564A2 Treatment of pathologies which escape the immune response, using optimised antibodies |
| 04/08/2004 | WO2003105769A3 Synthetic c-glycolipid and its use for treating cancer infectious diseases and autoimmune diseases |
| 04/08/2004 | WO2003102207A3 Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments |
| 04/08/2004 | WO2003095459A3 Alkaloid-derived compounds and use thereof in cancer and malaria treatment |
| 04/08/2004 | WO2003076602A3 Use of l-$g(a)-lysophosphatidycholine to obtain the differentiation of monocytes in mature dendritric cells in vivo |
| 04/08/2004 | WO2003075956A3 Use of mixtures of lipopeptides for vaccine production |
| 04/08/2004 | WO2003066077A3 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1) |
| 04/08/2004 | WO2001087839A8 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity |
| 04/08/2004 | US20040068207 Active oxygen generator containing photosensitizer for ultrasonic therapy |
| 04/08/2004 | US20040068122 Delta1-pyrrolines used as pesticides |
| 04/08/2004 | US20040068094 Ring modified cyclic peptide analogs |
| 04/08/2004 | US20040067998 Oral administering |
| 04/08/2004 | US20040067927 Substituted alkyldiamines |
| 04/08/2004 | US20040067236 In combination with a Th1-inducing adjuvant; vaccines |
| 04/08/2004 | CA2498383A1 Treatment of pathologies which escape the immune response, using optimised antibodies |
| 04/07/2004 | EP1405645A1 Remedies for eosinophilic diseases |
| 04/07/2004 | EP1405083A2 Natural ligand of gpcr chemr23 and uses thereof |
| 04/07/2004 | EP1404817A2 Use of oxidised lipoproteins for differentiation of precursor cells into mature dendritic cells |
| 04/07/2004 | EP1404714A2 Nuclear hormone receptor ligand binding domain |
| 04/07/2004 | EP1404703A2 G-protein coupled receptors |
| 04/07/2004 | EP1404665A1 Antimicrobial and radioprotective compounds |
| 04/07/2004 | EP1404350A2 Proteins associated with cell growth, differentiation, and death |
| 04/07/2004 | EP1404295A2 Sustained release drug delivery devices with coated drug cores |
| 04/07/2004 | CN1487939A Amido ether substituted imidazoquinolines |
| 04/07/2004 | CN1487930A Novel substituted 1,2,4-trioxanes useful as antimalarial agents and a process for the preparation thereof |
| 04/07/2004 | CN1487788A Pharmaceutical composition containing aminoacetonitril compounds and the use thereof for the preparation of a pharmacea-tical composition for the treatment of endoparasitic pests in animals |
| 04/07/2004 | CN1144799C N-(iminomethyl) amine derivatives, their preparation, their use as medicines and medical compositions containing the same |
| 04/06/2004 | US6716878 Antimicrobial agents |
| 04/06/2004 | US6716871 Cyclic AMP-specific phosphodie sterase inhibitors |
| 04/06/2004 | US6716442 Cyclic applying of pesticides |
| 04/06/2004 | CA2129430C N, n'-substituted imidocarbonimidic diamides derived from hydroxylamines |
| 04/01/2004 | WO2004026815A2 Phenol derivatives and their use as rotamase inhibitors |
| 04/01/2004 | WO2004018681A3 Il-7 drug substance, il- 7 comprising composition, preparation and uses thereof |
| 04/01/2004 | WO2004009762A9 Flea and tick octopamine receptor nucleic acid molecules, proteins and thereof |
| 04/01/2004 | WO2003106425A3 Phenyl- and pyridyl-diazaheterocycles having a tnf-modulating activity |
| 04/01/2004 | WO2003097597A3 Indole derivatives and the use thereof as cb2 receptor ligands |
| 04/01/2004 | WO2003081238A3 Cytocapacity test |
| 04/01/2004 | US20040063944 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives |
| 04/01/2004 | US20040063766 Pharmaceutical composition containing aminocetonitrile compounds and the use thereof for the preparation of a pharmaceutical composition for the treatment of endoparasitic pests in animals |
| 04/01/2004 | US20040063718 Targeted therapeutics and uses thereof |
| 04/01/2004 | US20040063709 Acute and chronic inflammatory disorders; cancer |
| 04/01/2004 | US20040063688 CCR1 receptor antagonists; such as 5-chloro-2-(2-(-3-(4-fluoro-phenoxy)-8-aza-bicyclo(3.2.1)oct-8-yl)-2-oxo -ethoxy)-benzamide |
| 04/01/2004 | US20040063677 Omega monounsaturated fatty acid derivativatized biologically active materials; drug delivery; drug resistance; bioavail-ability |
| 04/01/2004 | US20040063674 Tetracycline compounds having target therapeutic activities |
| 04/01/2004 | US20040063649 Azithromycin combination for emesis control in mammals |
| 04/01/2004 | US20040062772 Attenuated live neospora vaccine |
| 04/01/2004 | CA2498662A1 Phenol derivatives and their use as rotamase inhibitors |
| 03/31/2004 | EP1402903A1 Method of transporting physiological polymer using protein having rxp repeated sequence |
| 03/31/2004 | EP1402888A1 The use of substituted carbocyclic compounds as rotamases inhibitors |
| 03/31/2004 | EP1402054A1 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof |
| 03/31/2004 | EP1402039A1 MUTANT FORMS OF EtxB AND CtxB AND THEIR USE AS CARRIERS |
| 03/31/2004 | EP1401859A2 Chimeric flavivirus vectors |
| 03/31/2004 | EP1401453A2 Protease inhibitors |
| 03/31/2004 | EP1401377A2 Methods for treating cancer |
| 03/31/2004 | EP1401277A1 Amenoacetonitrile compounds for controlling endoparasites |
| 03/31/2004 | EP1049484B1 Use of il-11 to enhance cell mediated immunity for treating various viral and parasitic infections and cancer |
| 03/31/2004 | EP0871439B1 Substituted (aryl, heteroaryl, arylmethyl or heteroarylmethyl) hydroxamic acid compounds |
| 03/31/2004 | EP0772445B1 Pharmaceutical compositions, mainly vaginal suppository, containing many different active ingredients |
| 03/31/2004 | EP0666916B1 Plasmodium falciparum antigens inducing protective antibodies |
| 03/31/2004 | CN1486320A Inhibitors of cruzipain and other cysteine proteases |
| 03/31/2004 | CN1143854C Novel 2-(iminomethyl) amino-phenyl derivatives,the preparation thereof, application as medicines and pharmaceutical compositions containing same |
| 03/30/2004 | US6713487 Heterocyclic amine derivatives; for treating an inflammatory or immune disease, a cardiovascular disease, or a neurodegenerative condition |
| 03/30/2004 | US6713301 Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens |
| 03/30/2004 | CA2057760C Salinomycin biomass granules which are free-flowing and dust-free and have unrestricted bioavailability of active substance, and a process for the production thereof |
| 03/25/2004 | WO2004024889A2 Production of bispecific molecules using polyethylene glycol linkers |
| 03/25/2004 | WO2004024704A1 Organic compounds |
| 03/25/2004 | WO2004024151A1 Composition and potentiating method |